Tag: Ludwig N. Hantson

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ludwig N. Hantson

US Bancorp DE Lowers Holdings in Alexion Pharmaceuticals, Inc. (ALXN)

Added to Collection on: 2018-02-13 01:15:00

Tags for this article:

Business
Economy
Stock
Biotechnology
Alexion Pharmaceuticals
Eculizumab
David L. Hallal
Alexion Pharmaceuticals Inc.
Specialty drugs
Us Bancorp
Ludwig N. Hantson

Click the tags to see associated articles and topics

View Article Details
Alexion Pharmaceuticals, Inc. (ALXN) Shares Sold by Renaissance Technologies LLC

Added to Collection on: 2018-04-01 20:56:15

Tags for this article:

Business
Economy
Price?earnings ratio
Biotechnology
Alexion Pharmaceuticals
Eculizumab
David L. Hallal
Alexion Pharmaceuticals Inc.
Renaissance Technologies LLC
Specialty drugs
Ludwig N. Hantson

Click the tags to see associated articles and topics

View Article Details
First Trust Advisors LP Purchased in Alexion Pharmaceuticals Inc. (ALXN) Shares

Added to Collection on: 2018-04-04 10:26:15

Tags for this article:

Finance
Economy
NASDAQ
Stock
Biotechnology
First Trust Advisors LP
Alexion Pharmaceuticals
Alexion Pharmaceuticals Inc.
Ludwig N. Hantson

Click the tags to see associated articles and topics

View Article Details
Millennium Management LLC Reduces Position in Alexion Pharmaceuticals (ALXN)

Added to Collection on: 2018-05-03 13:03:45

Tags for this article:

Stock
Biotechnology
Pharmaceutical industry
Alexion Pharmaceuticals
Eculizumab
Alexion Pharmaceuticals Inc.
Specialty drugs
Ludwig N. Hantson
Life Sciences
Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details
Sofinnova Ventures Inc Invests $1.02 Million in Alexion Pharmaceuticals (NASDAQ:ALXN) Stock

Added to Collection on: 2018-06-26 19:30:04

Tags for this article:

Finance
Stock
Biotechnology
Pharmaceutical industry
Alexion Pharmaceuticals
Eculizumab
Specialty drugs
Ludwig N. Hantson
Sofinnova Ventures Inc

Click the tags to see associated articles and topics

View Article Details
Alexion Pharmaceuticals INC (ALXN) Shareholder Clearbridge LLC Has Raised Its Stake by ...

Added to Collection on: 2018-07-06 21:30:00

Tags for this article:

Economy
NASDAQ
Short
Biotechnology
NASDAQ-100
Alexion Pharmaceuticals
Specialty drugs
Ludwig N. Hantson

Click the tags to see associated articles and topics

View Article Details
As Alexion Pharmaceuticals (ALXN) Market Value Declined, Aqr Capital Management Trimmed Its ...

Added to Collection on: 2018-07-12 03:38:24

Tags for this article:

Economy
NASDAQ
Short
Biotechnology
New York Stock Exchange
Alexion Pharmaceuticals
Eculizumab
AT&T
AT&T Inc
Ludwig N. Hantson
Matrix Asset Advisors Inc

Click the tags to see associated articles and topics

View Article Details
AQR Capital Management LLC Sells 76824 Shares of Alexion Pharmaceuticals, Inc. (ALXN)

Added to Collection on: 2018-12-26 20:17:34

Tags for this article:

Biotechnology
Pharmaceutical industry
Health care
Alexion Pharmaceuticals
Eculizumab
Alexion Pharmaceuticals Inc.
Aqr Capital Management Llc
Specialty drugs
Ludwig N. Hantson

Click the tags to see associated articles and topics

View Article Details
AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development

Added to Collection on: 2020-12-12 12:45:00

Tags for this article:

Companies
Life Sciences
Mergers and acquisitions
Orphan drugs
AstraZeneca
Alexion Pharmaceuticals
Centerview Partners
Eculizumab
Evercore
Goldman Sachs
Ravulizumab
Ludwig N. Hantson
Ludwig Hantson
Boston
Alexion Pharmaceuticals Inc.
United States
United Kingdom

Click the tags to see associated articles and topics

View Article Details
AstraZeneca To Buy Former CT-Based Alexion In $39 Billion Deal

Added to Collection on: 2020-12-12 16:18:45

Tags for this article:

Life Sciences
Biotechnology
Specialty drugs
Health sciences
Ludwig N. Hantson
Eculizumab
Alexion Pharmaceuticals
AstraZeneca
Biopharmaceutical

Click the tags to see associated articles and topics

View Article Details
Book a Demo